Vol. 26 No. 3 (2022)
EXPERIMENTAL STUDIES

Technical features of a self-expandable prosthetic valve for the treatment of pulmonary valve disease

K.A. Rzaeva
Meshalkin National Medical Research Center
Bio
T.P. Timchenko
Meshalkin National Medical Research Center
I.Yu. Zhuravleva
Meshalkin National Medical Research Center
A.N. Arkhipov
Meshalkin National Medical Research Center
A.V. Gorbatykh
Almazov National Medical Research Centre
A.V. Voitov
Meshalkin National Medical Research Center
N.R. Nichay
Meshalkin National Medical Research Center
A.V. Bogachev-Prokophiev
Meshalkin National Medical Research Center
I.A. Soynov
Meshalkin National Medical Research Center

Published 2022-09-30

Keywords

  • Biocompatible Materials,
  • Bioprosthesis,
  • Heart Ventricles,
  • Nitinol,
  • Pulmonary Valve

How to Cite

Rzaeva, K., Timchenko, T., Zhuravleva, I., Arkhipov, A., Gorbatykh, A., Voitov, A., Nichay, N., Bogachev-Prokophiev, A., & Soynov, I. (2022). Technical features of a self-expandable prosthetic valve for the treatment of pulmonary valve disease. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 26(3), 85–90. https://doi.org/10.21688/1681-3472-2022-3-85-90

Abstract

Background. Balloon-expandable prostheses authorized for transcatheter pulmonary valve replacement in the Russian Federation have a barrel-shaped frame, which requires pre-stenting of a native right ventricular outflow tract or a conduit. This increases procedure duration, complicates implantation technique, and increases operation costs.
Aim. To develop a self-expandable pulmonary valve model for transcatheter replacement and prepare it for preclinical trials.
Methods. The model of a self-expandable pulmonary valve bioprothesis for transcatheter replacement made of nitinol was developed. The leaflets and the lining of the frame were made of porcine pericardium and assembled manually. Radial force testing was performed; valve loading into the delivery system was also tested.
Results. According to the results of the tests, the valve biomaterial and the suture sites were not damaged after compression. In 2022, initial preclinical tests are scheduled to determine viability of the implanted valves at 6 and 12 months after surgery, and the rate of calcification for this observation period is to be assessed as well.
Conclusion. By optimizing the design of the support frame, we improved the transcatheter model of the biological valve with satisfactory results at the initial stage of preclinical trials.

Received 22 April 2022. Revised 5 May 2022. Accepted 11 May 2022.

Funding: This work is supported by a grant of the Russian Science Foundation (project No. 21-75-10041).

Conflict of interest: Authors declare no conflict of interest.

Contribution of the authors
Conception and study design: K.A. Rzaeva, T.P. Timchenko, A.N. Arkhipov, N.R. Nichay
Data collection and analysis: A.V. Voitov, N.R. Nichay
Drafting the article: K.A. Rzaeva, A.V. Gorbatykh
Critical revision of the article: I.Yu. Zhuravleva, I.A. Soynov, A.V. Bogachev-Prokophiev
Final approval of the version to be published: K.A. Rzaeva, T.P. Timchenko, I.Yu. Zhuravleva, A.N. Arkhipov, A.V. Gorbatykh, A.V. Voitov, N.R. Nichay, A.V. Bogachev-Prokophiev, I.A. Soynov

References

  1. Сойнов И.А., Журавлева И.Ю., Кулябин Ю.Ю., Ничай Н.Р., Афанасьев А.В., Алешкевич Н.П., Богачев-Прокофьев А.В., Караськов А.М. Клапансодержащие кондуиты в детской кардиохирургии. Хирургия. Журнал им. Н.И. Пирогова. 2018;(1):75-81. https://doi.org/10.17116/hirurgia2018175-81 Soynov I.A., Zhuravleva I.Iu., Kulyabin Yu.Yu., Nichay N.R., Afanas'ev A.V., Aleshkevich N.P., Bogachev-Prokof'ev A.V., Karas'kov A.M. Valved conduits in pediatric cardiac surgery. Khirurgiya. Zurnal im. N.I. Pirogova = Pirogov Russian Journal of Surgery. 2018;(1):75-81. (In Russ.) https://doi.org/10.17116/hirurgia2018175-81
  2. McElhinney D.B., Sondergaard L., Armstrong A.K., Bergersen L., Padera R.F., Balzer D.T., Lung T.-H., Berger F., Zahn E.M., Gray R.G., Hellenbrand W.E., Kreutzer J., Eicken A., Jones T.K., Ewert P. Endocarditis after transcatheter pulmonary valve replacement. J Am Coll Cardiol. 2018;72(22):2717-2728. PMID: 30497557. https://doi.org/10.1016/j.jacc.2018.09.039
  3. Bonhoeffer P., Boudjemline Y., Saliba Z., Hausse A.O., Aggoun Y., Bonnet D., Sidi D., Kachaner J. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation. 2000;102(7):813-816. PMID: 10942752. https://doi.org/10.1161/01.cir.102.7.813
  4. Balzer D. Pulmonary Valve Replacement for Tetralogy of Fallot. Methodist Debakey Cardiovasc J. 2019;15(2):122-132. PMID: 31384375; PMCID: PMC6668735. https://doi.org/10.14797/mdcj-15-2-122
  5. Plessis J., Hascoët S., Baruteau A., Godart F., Le Gloan L., Warin Fresse K., Tahhan N., Riou J.-Y., Guyomarch B., Petit J., Guérin P. Edwards SAPIEN transcatheter pulmonary valve implantation: results from a French registry. JACC Cardiovasc Interv. 2018;11(19):1909-1916. PMID: 30219326. https://doi.org/10.1016/j.jcin.2018.05.050
  6. Shahanavaz S., Qureshi A.M., Levi D.S., Boudjemline Y., Peng L.F., Martin M.H., Bauser-Heaton H., Keeshan B., Asnes J.D., Jones T.K., Justino H., Aboulhosn J.A., Gray R.G., Nguyen H., Balzer D.T., McElhinney D.B. Transcatheter pulmonary valve replacement with the melody valve in small diameter expandable right ventricular outflow tract conduits. JACC Cardiovasc Interv. 2018;11(6):554-564. PMID: 29566801. https://doi.org/10.1016/j.jcin.2018.01.239
  7. Lindsay I., Aboulhosn J., Salem M., Levi D. Aortic root compression during transcatheter pulmonary valve replacement. Catheter Cardiovasc Interv. 2016;88(5):814-821. PMID: 27121036. https://doi.org/10.1002/ccd.26547
  8. Faccini A., Butera G. Tricuspid regurgitation as a complication of Edwards Sapien XT valve implantation in pulmonary position a problem to deal with. Catheter Cardiovasc Interv. 2018;91(5):927-931. PMID: 29405557. https://doi.org/10.1002/ccd.27527
  9. Hascoët S., Acar P., Boudjemline Y. Transcatheter pulmonary valvulation: current indications and available devices. Arch Cardiovasc Dis. 2014;107(11):625-634. PMID: 25444020. https://doi.org/10.1016/j.acvd.2014.07.048
  10. Virk S.A., Liou K., Chandrakumar D., Gupta S., Cao C. Percutaneous pulmonary valve implantation: A systematic review of clinical outcomes. Int J Cardiol. 2015;201:487-489. PMID: 26313872. https://doi.org/10.1016/j.ijcard.2015.08.119
  11. Nordmeyer J., Ewert P., Gewillig M., AlJufan M., Carminati M., Kretschmar O., Uebing A., Dähnert I., Röhle R., Schneider H., Witsenburg M., Benson L., Gitter R., Bökenkamp R., Mahadevan V., Berger F. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255-2264. PMID: 31005985. https://doi.org/10.1093/eurheartj/ehz201
  12. Levi D.S., Sinha S., Salem M.M., Aboulhosn J.A. Transcatheter native pulmonary valve and tricuspid valve replacement with the Sapien XT: Initial experience and development of a new delivery platform. Catheter Cardiovasc Interv. 2016;88(3):434-443. PMID: 27142960. https://doi.org/10.1002/ccd.26398
  13. van Steenberghe M., Schubert T., Gerelli S., Bouzin C., Guiot Y., Xhema D., Bollen X., Abdelhamid K., Gianello P. Porcine pulmonary valve decellularization with NaOH-based vs detergent process: preliminary in vitro and in vivo assessments. J Cardiothorac Surg. 2018;13(1):34. PMID: 29695259; PMCID: PMC5918872. https://doi.org/10.1186/s13019-018-0720-y